SOURCE: Cypress Bioscience Inc.

Cypress Bioscience Inc.

October 30, 2009 06:30 ET

Cypress Bioscience, Inc. to Present at Oppenheimer 20th Annual Healthcare Conference

SAN DIEGO, CA--(Marketwire - October 30, 2009) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Oppenheimer 20th Annual Healthcare Conference on November 3, 2009.

The Oppenheimer conference is being held at the Waldorf=Astoria Hotel in New York, NY. Ms. Johnson is scheduled to present on Tuesday, November 3rd at 1:00 p.m. Eastern Time. The audio broadcast of this presentation can be accessed at

A replay of the presentation will be available at the same web address as well as on Cypress' website,

About Cypress Bioscience

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella® (milnacipran HCI) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at

Contact Information

  • For additional information please contact

    Mary Gieson
    Investor Relations
    (858) 452-2323
    Email Contact